Topic

All

22
Aug
2018

Building Startups With Pharma Needs in Mind: Thong Le on The Long Run Podcast

Today’s guest on The Long Run podcast is Thong Le. Le is the CEO of Accelerator Life Science Partners. It’s a venture capital backed operation that starts and nurtures biotech startups in Seattle, New York, San Diego and other places outside the main industry clusters of Boston and San Francisco. Accelerator, founded in 2003, currently invests out of a $63...
Read More
8
Aug
2018

The Antibiotic Opportunity? Spero’s Ankit Mahadevia on The Long Run Podcast

Today’s guest on The Long Run podcast is Ankit Mahadevia. Mahadevia is the CEO of Cambridge, Mass.-based Spero Therapeutics. It’s an antibiotic developer. Specifically, it’s focused on new strategies for fighting gram-negative bacterial infections that are increasingly resistant to our existing set of antibiotics. Despite persistent warnings from global health authorities about the rise of multi-drug resistant bugs, and the...
Read More
25
Jul
2018

Finding the ‘Middle Market’ of Biotech VC: Chris Garabedian on The Long Run Podcast

Today’s guest on The Long Run podcast is Chris Garabedian. Garabedian is best known for his controversial stint as CEO of Cambridge, Mass.-based Sarepta Therapeutics, the developer of treatments for Duchenne Muscular Dystrophy. Whatever you may think of his tenure there — and the FDA’s decision to approve eteplirsen on a slim reed of clinical trial evidence – there is...
Read More